Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2011

Oct 25, 2011

30681_dirs_2011-10-25_702907c0-4655-4686-b8a9-448e09f2f147.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-10-21

Reporting Person: SHEEHAN ANDREW T (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-10-21 Common Stock J 18601.0000 $0.0000 Acquired 37985.0000 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-10-21 Common Stock Warrant $2.7700 J 1167.0000 Acquired 2015-03-24 Common Stock (1167.0000) Indirect
2011-10-21 Common Stock Warrant $2.7700 J 181.0000 Acquired 2015-03-24 Common Stock (181.0000) Indirect
2011-10-21 Common Stock Warrant $2.9600 J 1035.0000 Acquired 2013-04-21 Common Stock (1035.0000) Indirect

Footnotes

F1: Distribution of shares without consideration to Managing Directors of the General Partner of Sutter Hill Ventures, A California Limited Partnership, in accordance with the partnership agreement.

F2: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.